Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
暂无分享,去创建一个
E. Cook | R. Soiffer | J. Antin | Stephanie K. Lee | Stephanie J Lee | E.Francis Cook | Stephanie J. Lee
[1] J. Garcia-conde,et al. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study , 1998, Bone Marrow Transplantation.
[2] N. Ueno,et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Garcia-conde,et al. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT. , 1997, Haematologica.
[4] A. Bonomi,et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale , 1997, Bone Marrow Transplantation.
[5] G H Guyatt,et al. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.
[6] J. Garcia-conde,et al. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT. , 1998, Bone marrow transplantation.
[7] P. Thall,et al. Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. , 2001, Blood.
[8] Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. , 1989, Blood.
[9] K. Sullivan,et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. , 1997, Blood.
[10] D A Bloch,et al. Capturing the patient's view of change as a clinical outcome measure. , 1999, JAMA.
[11] H. Atkins,et al. Quality of life following bone marrow transplantation: a comparison of patient reports with population norms , 1997, Bone Marrow Transplantation.
[12] John E. Ware,et al. SF-36 physical and mental health summary scales : a user's manual , 1994 .
[13] J P Klein,et al. Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission. , 2000, Blood.
[14] J. Bourhis,et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Radich,et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. , 2001, Blood.
[16] H. Deeg,et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease. , 1988, Blood.
[17] G. Guyatt,et al. Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.
[18] H. Deeg,et al. Prednisone and Azathioprine Compared With Prednisone and Placebo for Treatment of Chronic Graft-v-Host Disease : Prognostic Influence of Prolonged Thrombocytopenia After Allogeneic Marrow Transplantation , 2005 .
[19] John P Klein,et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. , 2002, Blood.
[20] P. Mahendra,et al. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study , 1998, Bone Marrow Transplantation.
[21] M. Beksac,et al. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] J. V. Stone,et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. , 1999, The New England journal of medicine.
[23] J. V. Stone,et al. Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation , 1999 .
[24] A. Santoro,et al. High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. , 1996, Bone marrow transplantation.
[25] A. Tichelli,et al. Health and Functional Status of Long-Term Survivors of Bone Marrow Transplantation , 1997, Annals of Internal Medicine.
[26] J. Klein,et al. Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remission , 2000 .
[27] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.
[28] J. Ware. SF-36 health survey: Manual and interpretation guide , 2003 .
[29] J. Sloan. Asking the obvious questions regarding patient burden. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] R. Epstein,et al. Interpretation of quality of life changes , 1993, Quality of Life Research.
[31] D. Osoba,et al. Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] K. Sullivan,et al. Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. , 1990, Blood.
[33] D. Paniagua,et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] K. Sullivan,et al. Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. , 1993, Bone marrow transplantation.